Vertex Pharmaceuticals

$180.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.06 (-2.20%) Today
$0.00 (0.00%) As of 4:21 PM EDT after-hours

Why Robinhood?

You can buy or sell VRTX and other stocks, options, ETFs, and crypto commission-free!

About VRTX

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Employees
2,500
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
46.31B
Price-Earnings Ratio
21.12
Dividend Yield
0.00
Average Volume
1.08M
High Today
$186.78
Low Today
$179.24
Open Price
$184.36
Volume
1.20M
52 Week High
$195.81
52 Week Low
$151.80

Collections

VRTX News

ReutersAug 6

Edited Transcript of VRTX earnings conference call or presentation 31-Jul-19 8:30pm GMT

11
Barron'sAug 2

Vertex Pharmaceuticals Stock Soared on a Strong Earnings Report

61
FortuneJul 25

A $43 Billion Biotech Now Has a Female CEO

37

VRTX Earnings

$0.53
$0.79
$1.04
$1.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 30, After Hours

More VRTX News

MarketWatchJul 25

Vertex Pharmaceuticals names Chief Medical Officer Reshma Kewalramani as new CEO

215
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.